Related Experiment Video
Updated: Mar 14, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Calcitriol Reduces Hepatic Triglyceride Accumulation and Glucose Output Through Ca2+/CaMKKβ/AMPK Activation Under
1Room 609A, Lo Kwee- Seong Integrated Biomedical Sciences Building, School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. psleung@cuhk.edu.hk.
Objectives:
The present study was designed to investigate the effects of calcitriol (the active hormonal metabolite of vitamin D) on hepatic metabolic abnormalities in type 2 diabetes.
Methods:
Type 2 diabetic db/db mice were used to investigate the effects of calcitriol on hepatic and systemic metabolic disorders. HepG2 cells cultured in insulin-resistant conditions were used to examine the potential mechanisms for calcitriol-induced changes in hepatic lipid and glucose metabolism.
Results:
8-week calcitriol treatment ameliorated abnormal hepatic lipid and glucose production in db/db mice. In HepG2 cells under insulin-resistant condition, calcitriol increased cytosolic calcium concentration and induced 5'-AMP-activated protein kinase/acetyl-CoAcarboxylase (AMPK/ACC) phosphorylation via the Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) pathway, contributing to the reductions in hepatic triglyceride accumulation and glucose output. Calcitriol also induced AMPK/ACC phosphorylation in liver of db/db mice.
Conclusion:
Our data indicate that calcitriol, at above-physiological serum concentrations, reduces hepatic triglyceride accumulation and glucose output, at least in part through activation of Ca2+/CaMKKβ/AMPK under insulin-resistant condition.
Insights
Calcitriol, vitamin D
Area of Science:
- Endocrinology
- Metabolic Diseases
- Molecular Biology
Background:
- Type 2 diabetes is characterized by hepatic metabolic abnormalities.
- Vitamin D deficiency is common in type 2 diabetes patients.
- Calcitriol is the active form of vitamin D.
Purpose of the Study:
- To investigate the effects of calcitriol on hepatic metabolic abnormalities in type 2 diabetes.
- To elucidate the underlying mechanisms of calcitriol's action in insulin resistance.
Main Methods:
- Type 2 diabetic db/db mice and insulin-resistant HepG2 cells were utilized.
- Calcitriol treatment was administered for 8 weeks in vivo.
- Cellular signaling pathways, including Ca2+/CaMKKβ/AMPK, were examined.
Main Results:
- Calcitriol treatment improved hepatic lipid and glucose metabolism in diabetic mice.
- In insulin-resistant cells, calcitriol activated the Ca2+/CaMKKβ/AMPK pathway.
- This activation led to reduced hepatic triglyceride accumulation and glucose output.
Conclusions:
- Calcitriol effectively ameliorates hepatic metabolic dysfunction in type 2 diabetes.
- The Ca2+/CaMKKβ/AMPK pathway is a key mediator of calcitriol's beneficial effects.
- Calcitriol shows therapeutic potential for managing type 2 diabetes complications.
More Related Videos
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
08:01Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Diabetes Mellitus: Type 2 and Gestational
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...